HK1063321A1 - New Ä3,4-A:3,4-CÜcarbazole compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New Ä3,4-A:3,4-CÜcarbazole compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HK1063321A1 HK1063321A1 HK04106087A HK04106087A HK1063321A1 HK 1063321 A1 HK1063321 A1 HK 1063321A1 HK 04106087 A HK04106087 A HK 04106087A HK 04106087 A HK04106087 A HK 04106087A HK 1063321 A1 HK1063321 A1 HK 1063321A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cücarbazole
- compounds
- preparation
- new
- pharmaceutical compositions
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1063321A1 true HK1063321A1 (en) | 2004-12-24 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04106087A HK1063321A1 (en) | 2002-10-16 | 2004-08-13 | New Ä3,4-A:3,4-CÜcarbazole compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (es) |
| EP (1) | EP1411057B1 (es) |
| JP (1) | JP2004277404A (es) |
| KR (1) | KR100502250B1 (es) |
| CN (1) | CN1241925C (es) |
| AR (1) | AR041618A1 (es) |
| AT (1) | ATE294181T1 (es) |
| AU (1) | AU2003254746A1 (es) |
| BR (1) | BR0304575A (es) |
| CA (1) | CA2443585A1 (es) |
| DE (1) | DE60300571T2 (es) |
| DK (1) | DK1411057T3 (es) |
| EA (1) | EA007250B1 (es) |
| ES (1) | ES2240927T3 (es) |
| FR (1) | FR2845996A1 (es) |
| HK (1) | HK1063321A1 (es) |
| MA (1) | MA27007A1 (es) |
| MX (1) | MXPA03009362A (es) |
| MY (1) | MY134620A (es) |
| NO (1) | NO20034614L (es) |
| NZ (1) | NZ528902A (es) |
| PL (1) | PL362885A1 (es) |
| PT (1) | PT1411057E (es) |
| SG (1) | SG131765A1 (es) |
| SI (1) | SI1411057T1 (es) |
| ZA (1) | ZA200308053B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| WO2008109591A1 (en) | 2007-03-08 | 2008-09-12 | Lexicon Pharmaceuticals, Inc. | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| EP3105225A1 (en) | 2014-02-12 | 2016-12-21 | iTeos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| MX2016015005A (es) * | 2014-05-15 | 2017-09-28 | Iteos Therapeutics | Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1. |
| CA2979616C (en) | 2015-03-17 | 2020-04-28 | Pfizer Inc. | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法 |
| WO2017025868A1 (en) | 2015-08-10 | 2017-02-16 | Pfizer Inc. | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質ｂｅ―１３７９３ｃ |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 EP EP03292545A patent/EP1411057B1/fr not_active Expired - Lifetime
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active IP Right Cessation
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
-
2004
- 2004-08-13 HK HK04106087A patent/HK1063321A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL362885A1 (en) | 2004-04-19 |
| SG131765A1 (en) | 2007-05-28 |
| DK1411057T3 (da) | 2005-08-29 |
| CA2443585A1 (fr) | 2004-04-16 |
| ZA200308053B (en) | 2004-07-08 |
| PT1411057E (pt) | 2005-08-31 |
| US7151108B2 (en) | 2006-12-19 |
| AU2003254746A1 (en) | 2004-05-06 |
| EP1411057A1 (fr) | 2004-04-21 |
| SI1411057T1 (es) | 2005-08-31 |
| AR041618A1 (es) | 2005-05-26 |
| DE60300571T2 (de) | 2006-02-23 |
| EA007250B1 (ru) | 2006-08-25 |
| MY134620A (en) | 2007-12-31 |
| EA200301020A1 (ru) | 2004-04-29 |
| DE60300571D1 (de) | 2005-06-02 |
| KR20040034472A (ko) | 2004-04-28 |
| ES2240927T3 (es) | 2005-10-16 |
| ATE294181T1 (de) | 2005-05-15 |
| NO20034614L (no) | 2004-04-19 |
| MXPA03009362A (es) | 2004-04-28 |
| FR2845996A1 (fr) | 2004-04-23 |
| CN1496989A (zh) | 2004-05-19 |
| NZ528902A (en) | 2004-09-24 |
| KR100502250B1 (ko) | 2005-07-20 |
| EP1411057B1 (fr) | 2005-04-27 |
| JP2004277404A (ja) | 2004-10-07 |
| BR0304575A (pt) | 2004-07-20 |
| CN1241925C (zh) | 2006-02-15 |
| NO20034614D0 (no) | 2003-10-15 |
| US20040077672A1 (en) | 2004-04-22 |
| MA27007A1 (fr) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1042698B (zh) | 新的二苯脲化合物、其製備方法和含有該化合物的藥物組合物 | |
| AU2003239302A1 (en) | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them | |
| HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1039117B (zh) | 新的哌啶-4-磺酰胺化合物、其製備方法和含有它們的藥物組合物 | |
| HK1045517B (zh) | 環丁烯二酮化合物及其製備方法和含這些化合物的藥物組合物 | |
| HUP0203976A3 (en) | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them | |
| HK1063321A1 (en) | New Ä3,4-A:3,4-CÜcarbazole compounds, a process for their preparation and pharmaceutical compositions containing them | |
| AU2003231920A8 (en) | Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them | |
| HK1041605B (zh) | 新的1，1-和1，2-二取代的環丙烷化合物、其製備方法和含有它們的藥物組合物 | |
| ZA200302159B (en) | New compounds derived from quinazoline, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0202379A3 (en) | New compounds, process for producing them and pharmaceutical compositions containing them | |
| HK1049159B (zh) | 新的茚並吲哚酮化合物，其製備方法和含有這種化合物的藥物組合物 | |
| HK1049000B (zh) | 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物 | |
| EG24369A (en) | New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1042094B (zh) | 新型苯並噻二嗪化合物，其製備方法及含它們的藥物組合物 | |
| AU2002300093A1 (en) | New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1050681A1 (en) | New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HK1053646A1 (en) | BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1079775A1 (en) | New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1040247A1 (zh) | 新穎的環丁烷並吲羧酰胺化合物、其製備方法和含有它們的藥物組合物 | |
| HK1042477B (zh) | 新型雜環烷基苯並環丁烷和雜環芳基苯並環丁烷化合物，其製備方法和包含它們的藥物組合物 | |
| HUP0402417A3 (en) | N,n'-disubstituted piperazine compounds process for producing them, pharmaceutical compositions containing them and use thereof | |
| HUP0402418A3 (en) | Substituted 1,5-diaminopentan-3-ol compounds, process for producing them, pharmaceutical compositions containing them and use thereof | |
| ZA200204757B (en) | Indenoidolone compounds, a process for their preparation and pharmaceutical compositions containing them. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20091016 |